These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Platypnea-orthodeoxia after fibrotic evolution of SARS-CoV-2 interstitial pneumonia. A case report. Longo C; Ruffini L; Zanoni N; Longo F; Accogli R; Graziani T; Chetta A Acta Biomed; 2020 Aug; 91(3):ahead of print. PubMed ID: 32921749 [TBL] [Abstract][Full Text] [Related]
10. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263 [No Abstract] [Full Text] [Related]
11. Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease. Vannucci J; Ruberto F; Diso D; Galardo G; Mastroianni CM; Raponi G; Bassi M; Ceccarelli G; Mancone M; Antonelli G; Venuta F; Pugliese F; J Glob Antimicrob Resist; 2020 Dec; 23():67-69. PubMed ID: 32810641 [No Abstract] [Full Text] [Related]
12. The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection. Rigamonti E; Salera D; Gheorghiu AC; Fratila C; Gianella P Swiss Med Wkly; 2020 Jun; 150():w20312. PubMed ID: 32662060 [TBL] [Abstract][Full Text] [Related]
13. Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease. Tada Y; Suematsu E; Ueda A; Nagano S; Sawabe T; Nishizaka H; Horiuchi T Clin Exp Rheumatol; 2012; 30(3):450. PubMed ID: 22325787 [No Abstract] [Full Text] [Related]
14. Post COVID-19 Organizing Pneumonia: The Right Time to Interfere. Bieksiene K; Zaveckiene J; Malakauskas K; Vaguliene N; Zemaitis M; Miliauskas S Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803690 [TBL] [Abstract][Full Text] [Related]
15. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report. Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894 [TBL] [Abstract][Full Text] [Related]
16. Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Mehta P; Machado PM; Gupta L Rheumatol Int; 2021 Jun; 41(6):1021-1036. PubMed ID: 33774723 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous Imaging of Lung Perfusion and Glucose Metabolism in COVID-19 Pneumonia. Ramos CD; Fernandes AP; Souza SPM; Fujiwara M; Tobar N; Dertkigil SSJ; Takahashi MES; Gonçales ESL; Trabasso P; Zantut-Wittmann DE Am J Respir Crit Care Med; 2021 May; 203(9):1186-1187. PubMed ID: 33636089 [No Abstract] [Full Text] [Related]
18. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial. Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061 [TBL] [Abstract][Full Text] [Related]
19. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia]. ; Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435 [TBL] [Abstract][Full Text] [Related]
20. Interstitial lung disease in polymyositis and dermatomyositis. Fathi M; Lundberg IE Curr Opin Rheumatol; 2005 Nov; 17(6):701-6. PubMed ID: 16224246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]